271 related articles for article (PubMed ID: 35060325)
1. Risk assessment of venous thromboembolism and bleeding in COVID-19 patients.
Wang L; Zhao L; Li F; Liu J; Zhang L; Li Q; Gu J; Liang S; Zhao Q; Liu J; Xu JF
Clin Respir J; 2022 Mar; 16(3):182-189. PubMed ID: 35060325
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a "real life" prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study).
Depietri L; Marietta M; Scarlini S; Marcacci M; Corradini E; Pietrangelo A; Ventura P
Intern Emerg Med; 2018 Jun; 13(4):527-534. PubMed ID: 29502330
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 Infection in Critically Ill Patients Carries a High Risk of Venous Thrombo-embolism.
Bellmunt-Montoya S; Riera C; Gil D; Rodríguez M; García-Reyes M; Martínez-Carnovale L; Marrero C; Gil M; Ruiz-Rodríguez JC; Ferrer R; de Nadal M; Monreal M; Llagostera S
Eur J Vasc Endovasc Surg; 2021 Apr; 61(4):628-634. PubMed ID: 33583710
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Venous Thromboembolism Risks Between COVID-19 Pneumonia and Community-Acquired Pneumonia Patients.
Mei F; Fan J; Yuan J; Liang Z; Wang K; Sun J; Guan W; Huang M; Li Y; Zhang WW
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2332-2337. PubMed ID: 32628040
[TBL] [Abstract][Full Text] [Related]
5. Venous thromboembolism (VTE) prevention and diagnosis in COVID-19: Practice patterns and outcomes at 33 hospitals.
Parks AL; Auerbach AD; Schnipper JL; Bertram A; Jeon SY; Boyle B; Fang MC; Gadrey SM; Siddiqui ZK; Brotman DJ;
PLoS One; 2022; 17(5):e0266944. PubMed ID: 35511940
[TBL] [Abstract][Full Text] [Related]
6. Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis.
Jiménez D; García-Sanchez A; Rali P; Muriel A; Bikdeli B; Ruiz-Artacho P; Le Mao R; Rodríguez C; Hunt BJ; Monreal M
Chest; 2021 Mar; 159(3):1182-1196. PubMed ID: 33217420
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of patients with venous thromboembolism and COVID-19: Analysis of risk factors for death and major bleeding.
Demelo-Rodríguez P; Ordieres-Ortega L; Ji Z; Del Toro-Cervera J; de Miguel-Díez J; Álvarez-Sala-Walther LA; Galeano-Valle F
Eur J Haematol; 2021 May; 106(5):716-723. PubMed ID: 33608914
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Risk-Adjusted Heparin Regimens on the Outcome of Patients with COVID-19 Infection. A Prospective Cohort Study.
Di Micco P; Tufano A; Cardillo G; Imbalzano E; Amitrano M; Lodigiani C; Bellizzi A; Camporese G; Cavalli A; De Stefano C; Russo V; Voza A; Perrella A; Prandoni P
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578301
[TBL] [Abstract][Full Text] [Related]
9. Venous Thromboembolism and Major Bleeding in Patients With Coronavirus Disease 2019 (COVID-19): A Nationwide, Population-Based Cohort Study.
Dalager-Pedersen M; Lund LC; Mariager T; Winther R; Hellfritzsch M; Larsen TB; Thomsen RW; Johansen NB; Søgaard OS; Nielsen SL; Omland LH; Lundbo LF; Israelsen SB; Harboe ZB; Pottegård A; Nielsen H; Bodilsen J
Clin Infect Dis; 2021 Dec; 73(12):2283-2293. PubMed ID: 33400771
[TBL] [Abstract][Full Text] [Related]
10. New Insights in the Occurrence of Venous Thromboembolism in Critically Ill Patients with COVID-19-A Large Postmortem and Clinical Analysis.
Heinrich F; Roedl K; Jarczak D; Goebels HL; Heinemann A; Schäfer U; Ludwig F; Bachmann M; Bein B; Weber CF; Sydow K; Bota M; Paschen HR; de Weerth A; Veit C; Detsch O; Brand PA; Kluge S; Ondruschka B; Wichmann D
Viruses; 2022 Apr; 14(4):. PubMed ID: 35458541
[TBL] [Abstract][Full Text] [Related]
11. Bleeding and venous thromboembolism arising in acutely ill hospitalized medical patients. Findings from the Spanish national discharge database.
Guijarro R; San Roman C; Arcelus JI; Montes-Santiago J; Gómez-Huelgas R; Gallardo P; Monreal M
Eur J Intern Med; 2014 Feb; 25(2):137-41. PubMed ID: 24200547
[TBL] [Abstract][Full Text] [Related]
12. The Incidence of Venous Thromboembolism in Critically Ill Patients with SARS-CoV-2 Infection Compared with Critically Ill Influenza and Community-Acquired Pneumonia Patients: A Retrospective Chart Review.
Boyd S; Sheng Loh K; Lynch J; Alrashed D; Muzzammil S; Marsh H; Masoud M; Bin Ihsan S; Martin-Loeches I
Med Sci (Basel); 2022 Jun; 10(2):. PubMed ID: 35736350
[TBL] [Abstract][Full Text] [Related]
13. Incidence of venous thromboembolism in hospitalized patients with COVID-19.
Middeldorp S; Coppens M; van Haaps TF; Foppen M; Vlaar AP; Müller MCA; Bouman CCS; Beenen LFM; Kootte RS; Heijmans J; Smits LP; Bonta PI; van Es N
J Thromb Haemost; 2020 Aug; 18(8):1995-2002. PubMed ID: 32369666
[TBL] [Abstract][Full Text] [Related]
14. External validation of the VTE-BLEED score for predicting major bleeding in stable anticoagulated patients with venous thromboembolism.
Klok FA; Barco S; Konstantinides SV
Thromb Haemost; 2017 Jun; 117(6):1164-1170. PubMed ID: 28276566
[TBL] [Abstract][Full Text] [Related]
15. Investigation of two general venous thromboembolism risk-stratification models in predicting venous thromboembolic events in TB patients.
Sharif-Kashani B; Azimi M; Tabarsi P; Sadr M; Shirzadi S
Int J Mycobacteriol; 2022; 11(1):83-87. PubMed ID: 35295028
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors of Venous Thromboembolism in Noncritically Ill Patients Hospitalized for Acute COVID-19 Pneumonia Receiving Prophylactic-Dose Anticoagulation.
Poletto F; Spiezia L; Simion C; Campello E; Dalla Valle F; Tormene D; Camporese G; Simioni P
Viruses; 2022 Mar; 14(4):. PubMed ID: 35458467
[TBL] [Abstract][Full Text] [Related]
17. Association between pre-admission anticoagulation and in-hospital death, venous thromboembolism, and major bleeding among hospitalized COVID-19 patients in Japan.
Adomi M; Kuno T; Komiyama J; Taniguchi Y; Abe T; Miyawaki A; Imai S; Morita K; Saito M; Ohbe H; Kamio T; Tamiya N; Iwagami M
Pharmacoepidemiol Drug Saf; 2022 Jun; 31(6):680-688. PubMed ID: 35324035
[TBL] [Abstract][Full Text] [Related]
18. The risk of venous thromboembolism and blood hyperlactatemia is associated with increased mortality among critically ill patients with Covid-19.
Alshammary AF; AlQarni HM; Farzan R; Ali Khan I; Vennu V
Clin Respir J; 2023 Jun; 17(6):580-588. PubMed ID: 37144596
[TBL] [Abstract][Full Text] [Related]
19. Venous thromboembolism in COVID-19 patients and prediction model: a multicenter cohort study.
Lee Y; Jehangir Q; Li P; Gudimella D; Mahale P; Lin CH; Apala DR; Krishnamoorthy G; Halabi AR; Patel K; Poisson L; Balijepally V; Sule AA; Nair GB
BMC Infect Dis; 2022 May; 22(1):462. PubMed ID: 35562677
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action.
Pavoni V; Gianesello L; Pazzi M; Stera C; Meconi T; Frigieri FC
Thromb Res; 2020 Dec; 196():313-317. PubMed ID: 32977129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
